Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.310.100.10

What is the latest Fixed Capital/Sales ratio of TRIDENT LIFELINE ?

The latest Fixed Capital/Sales ratio of TRIDENT LIFELINE is 0.31 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.31
Mar20230.10
Mar20220.10

How is Fixed Capital/Sales of TRIDENT LIFELINE Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.31
210.00
Mar2023 0.1
0.00
Mar2022 0.1 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Fixed Capital/Sales ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹286.9 Cr 4.9% -4.9% 33.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,213.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹150,403.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹117,415.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,791.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹92,228.2 Cr -0.9% -10% -11.3% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

4.9%

-4.9%

33.5%

SENSEX

0.4%

-4.9%

-0.1%


You may also like the below Video Courses